Compositions Comprising Synthetic Polynucleotides Encoding Crispr Related Proteins And Synthetic Sgrnas And Methods Of Use - EP3019619

The patent EP3019619 was granted to Moderna on Aug 25, 2021. The application was originally filed on Jul 11, 2014 under application number EP14823392A. The patent is currently recorded with a legal status of "Granted And Under Opposition".

EP3019619

MODERNA
Application Number
EP14823392A
Filing Date
Jul 11, 2014
Status
Granted And Under Opposition
Jul 23, 2021
Grant Date
Aug 25, 2021
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions (2)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

MAIWALDMay 25, 2022MAIWALDADMISSIBLE
VOSSIUS & PARTNER PATENTANWALTE RECHTSANWALTE MBBApr 1, 2022VOSSIUS & PARTNER PATENTANWALTE RECHTSANWALTE MBBADMISSIBLE

Patent Citations (271) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication NumberPublication Link
DESCRIPTIONUS19700611757-
DESCRIPTIONUS20030073619-
DESCRIPTIONWO2013US30059-
DESCRIPTIONWO2013US30060-
DESCRIPTIONWO2013US30061-
DESCRIPTIONWO2013US30062-
DESCRIPTIONWO2013US30063-
DESCRIPTIONWO2013US30064-
DESCRIPTIONWO2013US30066-
DESCRIPTIONWO2013US30067-
DESCRIPTIONWO2013US30068-
DESCRIPTIONWO2013US30070-
DESCRIPTIONWO2013US31821-
DESCRIPTIONUS2004171980
DESCRIPTIONUS2004236268
DESCRIPTIONUS2005059005
DESCRIPTIONUS2005222064
DESCRIPTIONUS2005261218
DESCRIPTIONUS2007117112
DESCRIPTIONUS2008166414
DESCRIPTIONUS2008275468
DESCRIPTIONUS2009042825
DESCRIPTIONUS2009042829
DESCRIPTIONUS2009227660
DESCRIPTIONUS2010003337
DESCRIPTIONUS2010004313
DESCRIPTIONUS2010004315
DESCRIPTIONUS2010009424
DESCRIPTIONUS2010036115
DESCRIPTIONUS2010068285
DESCRIPTIONUS2010068286
DESCRIPTIONUS2010069426
DESCRIPTIONUS2010075072
DESCRIPTIONUS2010087337
DESCRIPTIONUS2010104645
DESCRIPTIONUS2010104655
DESCRIPTIONUS2010120024
DESCRIPTIONUS2010129877
DESCRIPTIONUS2010196983
DESCRIPTIONUS2010215580
DESCRIPTIONUS2010216804
DESCRIPTIONUS2010260817
DESCRIPTIONUS2010303850
DESCRIPTIONUS2010324120
DESCRIPTIONUS2011020388
DESCRIPTIONUS2011027217
DESCRIPTIONUS2011171248
DESCRIPTIONUS2011217377
DESCRIPTIONUS2011218231
DESCRIPTIONUS2011223201
DESCRIPTIONUS2011262491
DESCRIPTIONUS2011274759
DESCRIPTIONUS2011294717
DESCRIPTIONUS2012004293
DESCRIPTIONUS2012009145
DESCRIPTIONUS2012121718
DESCRIPTIONUS2012140790
DESCRIPTIONUS2012171229
DESCRIPTIONUS2012178702
DESCRIPTIONUS2012189700
DESCRIPTIONUS2013115272
DESCRIPTIONUS2013259924
DESCRIPTIONUS4587044
DESCRIPTIONUS4605735
DESCRIPTIONUS4667025
DESCRIPTIONUS4762779
DESCRIPTIONUS4789737
DESCRIPTIONUS4824941
DESCRIPTIONUS4828979
DESCRIPTIONUS4835263
DESCRIPTIONUS4876335
DESCRIPTIONUS4904582
DESCRIPTIONUS4948882
DESCRIPTIONUS4958013
DESCRIPTIONUS4981957
DESCRIPTIONUS5082830
DESCRIPTIONUS5109124
DESCRIPTIONUS5112963
DESCRIPTIONUS5118800
DESCRIPTIONUS5118802
DESCRIPTIONUS5138045
DESCRIPTIONUS5208020
DESCRIPTIONUS5214136
DESCRIPTIONUS5218105
DESCRIPTIONUS5245022
DESCRIPTIONUS5254469
DESCRIPTIONUS5258506
DESCRIPTIONUS5262536
DESCRIPTIONUS5272250
DESCRIPTIONUS5292873
DESCRIPTIONUS5317098
DESCRIPTIONUS5319080
DESCRIPTIONUS5359044
DESCRIPTIONUS5371241
DESCRIPTIONUS5391723
DESCRIPTIONUS5393878
DESCRIPTIONUS5414077
DESCRIPTIONUS5416203
DESCRIPTIONUS5446137
DESCRIPTIONUS5451413
DESCRIPTIONUS5466786
DESCRIPTIONUS5475092
DESCRIPTIONUS5486603
DESCRIPTIONUS5510475
DESCRIPTIONUS5512439
DESCRIPTIONUS5512667
DESCRIPTIONUS5514785
DESCRIPTIONUS5519134
DESCRIPTIONUS5525465
DESCRIPTIONUS5539082
DESCRIPTIONUS5541313
DESCRIPTIONUS5545730
DESCRIPTIONUS5552538
DESCRIPTIONUS5565552
DESCRIPTIONUS5567810
DESCRIPTIONUS5567811
DESCRIPTIONUS5574142
DESCRIPTIONUS5576427
DESCRIPTIONUS5578717
DESCRIPTIONUS5578718
DESCRIPTIONUS5580731
DESCRIPTIONUS5585481
DESCRIPTIONUS5585499
DESCRIPTIONUS5587371
DESCRIPTIONUS5591584
DESCRIPTIONUS5591722
DESCRIPTIONUS5595726
DESCRIPTIONUS5597696
DESCRIPTIONUS5597909
DESCRIPTIONUS5599923
DESCRIPTIONUS5599928
DESCRIPTIONUS5608046
DESCRIPTIONUS5610300
DESCRIPTIONUS5627053
DESCRIPTIONUS5639873
DESCRIPTIONUS5646265
DESCRIPTIONUS5658873
DESCRIPTIONUS5670633
DESCRIPTIONUS5688941
DESCRIPTIONUS5700920
DESCRIPTIONUS5714331
DESCRIPTIONUS5719262
DESCRIPTIONUS5846545
DESCRIPTIONUS6177274
DESCRIPTIONUS6190315
DESCRIPTIONUS6217912
DESCRIPTIONUS6234990
DESCRIPTIONUS6267987
DESCRIPTIONUS6268490
DESCRIPTIONUS6294664
DESCRIPTIONUS6320017
DESCRIPTIONUS6491657
DESCRIPTIONUS6517869
DESCRIPTIONUS6576752
DESCRIPTIONUS6586524
DESCRIPTIONUS6652886
DESCRIPTIONUS6670461
DESCRIPTIONUS6696038
DESCRIPTIONUS6783931
DESCRIPTIONUS6794499
DESCRIPTIONUS6900297
DESCRIPTIONUS6998484
DESCRIPTIONUS7037646
DESCRIPTIONUS7053207
DESCRIPTIONUS7084125
DESCRIPTIONUS7374930
DESCRIPTIONUS7385034
DESCRIPTIONUS7399845
DESCRIPTIONUS7404969
DESCRIPTIONUS7413875
DESCRIPTIONUS7833992
DESCRIPTIONUS7893302
DESCRIPTIONUS7964571
DESCRIPTIONUS7964578
DESCRIPTIONUS7994304
DESCRIPTIONUS8057821
DESCRIPTIONUS8101385
DESCRIPTIONUS8124379
DESCRIPTIONUS8206747
DESCRIPTIONUS8211473
DESCRIPTIONUS8236330
DESCRIPTIONUS8246968
DESCRIPTIONWO2008078180
DESCRIPTIONWO2008103276
DESCRIPTIONWO2008121949
DESCRIPTIONWO2010005721
DESCRIPTIONWO2010005723
DESCRIPTIONWO2010005725
DESCRIPTIONWO2010005726
DESCRIPTIONWO2010005740
DESCRIPTIONWO2010021865
DESCRIPTIONWO2010030763
DESCRIPTIONWO2010080724
DESCRIPTIONWO2010123569
DESCRIPTIONWO2010129709
DESCRIPTIONWO2010138192
DESCRIPTIONWO2010138193
DESCRIPTIONWO2010138194
DESCRIPTIONWO2011022460
DESCRIPTIONWO2011043913
DESCRIPTIONWO2011072218
DESCRIPTIONWO2011084513
DESCRIPTIONWO2011084518
DESCRIPTIONWO2011084521
DESCRIPTIONWO2011085231
DESCRIPTIONWO2011090965
DESCRIPTIONWO2011115862
DESCRIPTIONWO2011127255
DESCRIPTIONWO2011149733
DESCRIPTIONWO2011153120
DESCRIPTIONWO2012006376
DESCRIPTIONWO2012019168
DESCRIPTIONWO2012040184
DESCRIPTIONWO2012044638
DESCRIPTIONWO2012045075
DESCRIPTIONWO2012054365
DESCRIPTIONWO2012054923
DESCRIPTIONWO2012061259
DESCRIPTIONWO2012068187
DESCRIPTIONWO2012082574
DESCRIPTIONWO2012094304
DESCRIPTIONWO2012099755
DESCRIPTIONWO2012099805
DESCRIPTIONWO2013052523
DESCRIPTIONWO2013086486
DESCRIPTIONWO2013086502
DESCRIPTIONWO2013086505
DESCRIPTIONWO2013090648
DESCRIPTIONWO2013102203
INTERNATIONAL-SEARCH-REPORTUS2010273220
INTERNATIONAL-SEARCH-REPORTUS7691569
INTERNATIONAL-SEARCH-REPORTWO2012135805
INTERNATIONAL-SEARCH-REPORTWO2012164565
OPPOSITIONEP2518144
OPPOSITIONEP3134131
OPPOSITIONEP3590949
OPPOSITIONEP3682905
OPPOSITIONEP3718565
OPPOSITIONEP4108671
OPPOSITIONUS2005235369
OPPOSITIONUS2006240554
OPPOSITIONUS2006292572
OPPOSITIONUS2007161031
OPPOSITIONUS2008220983
OPPOSITIONUS2011182980
OPPOSITIONUS2012065252
OPPOSITIONWO0157182
OPPOSITIONWO0200677
OPPOSITIONWO0218424
OPPOSITIONWO03054166
OPPOSITIONWO2004042054
OPPOSITIONWO2004108883
OPPOSITIONWO2005028617
OPPOSITIONWO2006023491
OPPOSITIONWO2006028967
OPPOSITIONWO2008112127
OPPOSITIONWO2009074968
OPPOSITIONWO2010037539
OPPOSITIONWO2011005861
OPPOSITIONWO2011008260
OPPOSITIONWO2011150241
OPPOSITIONWO2012045075
OPPOSITIONWO2012135805
OPPOSITIONWO2013052523
OPPOSITIONWO2013071047
OPPOSITIONWO2013082519
OPPOSITIONWO2013090648
OPPOSITIONWO2014165825
OPPOSITIONWO2015006498
OPPOSITIONWO2015164674
SEARCHWO2009042971

Non-Patent Literature (NPL) Citations (82) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference TextLink
OPPOSITION- Addgene, Database accession no. MLM3613(Plasmid #42251), URL: https://www.addgene.org/42251/-
OPPOSITION- A Mccaffrey, "The Buzz on the Cut: From Dream to Reality - Zone in With ZonZone in With Zon", (20130701), pages 1 - 16, URL: http://zon.trilinkbiotech.com/2013/07/01/the-buzz-on-the-cut-from-dream-to-reality/, (20141218), XP055159475-
OPPOSITION- CONG LE ET AL, "Multiplex Genome Engineering Using CRISPR/Cas Systems", Science, American Association for the Advancement of Science, US, US , (20130201), vol. 339, no. 6121, ISSN 0036-8075, pages 819 - 823, XP002779503-
OPPOSITION- D183: Amended claims filed in EP 4108671-
OPPOSITION- Gascón Rodríguez Alicia, Ana Del Pozo, Maria Ángeles Solinís, "Chapter 1. Non-Viral Delivery Systems Gene Therapy", Gene Therapy - Tools and Potential Applications, INTECH, (20130101), pages 3 - 33, XP055932473-
OPPOSITION- Kenong Xu, "The Next Generation Biotechnology for Apple Improvement and Beyond: The CRISPR/Cas9 Story", New York Fruit Quarterly, (20130101), vol. 21, no. 4, pages 19 - 22, XP055340191-
OPPOSITION- Natalia Freitas, Cunha Celso, "Mechanisms and Signals for the Nuclear Import of Proteins", Current Genomics, (20090101), vol. 10, no. 29, pages 550 - 557, XP055502464-
OPPOSITION- VAN TENDELOO VIGGO FI, PONSAERTS PETER, BERNEMAN ZWI N, "mRNA-based gene transfer as a tool for gene and cell therapy.", CURRENT OPINION IN MOLECULAR THERAPEUTICS, CURRENT DRUGS, London, GB, London, GB , (20071001), vol. 9, no. 5, ISSN 1464-8431, pages 423 - 431, XP008090512-
OPPOSITION- Carissa L. Young, Zachary T. Britton, Anne S. Robinson, "Recombinant protein expression and purification: A comprehensive review of affinity tags and microbial applications", Biotechnology Journal, Wiley, (20120510), vol. 7, no. 5, doi:10.1002/biot.201100155, ISSN 18606768, pages 620 - 634, XP055104740
OPPOSITION- Pardi Norbert; Muramatsu Hiromi; Weissman Drew; Karikó Katalin, "In vitro transcription of long RNA containing modified nucleosides.", Synthetic Messenger RNA and Cell Metabolism Modulation - Series: Methods in molecular biology (Clifton, N.J.) ISSN 1940-6029, US , (Clifton, N.J.)United States2013 , (20130101), vol. 969, pages 29 - 42, doi:10.1007/978-1-62703-260-5_2, ISBN 978-1-62703-259-9, XP009509413
OPPOSITION- Stacey S. Patterson ; Hebe. M. Dionisi ; Rakesh K. Gupta ; Gary S. Sayler, "Codon optimization of bacterial luciferase (lux) for expression in mammalian cells", Journal of Industrial Microbiology & Biotechnology, Springer, Berlin, DE, Berlin, DE , (20050301), vol. 32, no. 3, doi:10.1007/s10295-005-0211-8, ISSN 1476-5535, pages 115 - 123, XP019357719
OPPOSITION- Murugaiah Veeravagu, Zedalis William, Lavine Gary, Charisse Klaus, Manoharan Muthiah, "Reversed-phase high-performance liquid chromatography method for simultaneous analysis of two liposome-formulated short interfering RNA duplexes", Analytical Biochemistry, Academic Press, Amsterdam, NL, Amsterdam, NL , (20100601), vol. 401, no. 1, doi:10.1016/j.ab.2010.02.012, ISSN 0003-2697, pages 61 - 67, XP055932461
OPPOSITION- Lei s. Qi, Matthew h. Larson, Luke a. Gilbert, Jennifer a. Doudna, Jonathan s. Weissman, Adam p. Arkin, Wendell a. Lim, "Repurposing CRISPR as an RNA-Guided Platform for Sequence-Specific Control of Gene Expression", Cell, Cell Press, (20130201), vol. 152, no. 5, doi:10.1016/j.cell.2013.02.022, ISSN 00928674, pages 1173 - 1183, XP055068548
OPPOSITION- Qi Lei S.; Larson Matthew H.; Gilbert Luke A.; Doudna Jennifer A.; Weissman Jonathan S.; Arkin Adam P.; Lim Wendell A. , "Repurposing CRISPR as an RNA-Guided Platform for Sequence-Specific Control of Gene Expression", Cell, Elsevier, Amsterdam NL, Amsterdam NL , (20130228), vol. 152, no. 5, doi:10.1016/j.cell.2013.02.022, ISSN 0092-8674, pages 1173 - 1183, XP028987304
OPPOSITION- Wang Haoyi; Yang Hui; Shivalila Chikdu S.; Dawlaty Meelad M.; Cheng Albert W.; Zhang Feng; Jaenisch Rudolf, "One-Step Generation of Mice Carrying Mutations in Multiple Genes by CRISPR/Cas-Mediated Genome Engineering", Cell, Elsevier, Amsterdam NL, Amsterdam NL , (20130509), vol. 153, no. 4, doi:10.1016/j.cell.2013.04.025, ISSN 0092-8674, pages 910 - 918, XP028538358
OPPOSITION- Gilbert Luke A.; Larson Matthew H.; Morsut Leonardo; Liu Zairan; Brar Gloria A.; Torres Sandra E.; Stern-Ginossar Noam; Brandman Onn; Whitehead Evan H.; Doudna Jennifer A.; Lim Wendell A.; Weissman Jonathan S.; Qi Lei S., "CRISPR-Mediated Modular RNA-Guided Regulation of Transcription in Eukaryotes", Cell, Elsevier, Amsterdam NL, Amsterdam NL , (20130718), vol. 154, no. 2, doi:10.1016/j.cell.2013.06.044, ISSN 0092-8674, pages 442 - 451, XP028680105
OPPOSITION- Luke a. Gilbert, Matthew h. Larson, Leonardo Morsut, Zairan Liu, Gloria a. Brar, Sandra e. Torres, Noam Stern-Ginossar, Onn Brandman, Evan h. Whitehead, Jennifer a. Doudna, Wendell a. Lim, Jonathan s. Weissman, Lei s. Qi, "CRISPR-Mediated Modular RNA-Guided Regulation of Transcription in Eukaryotes", Cell, Elsevier, Amsterdam NL, Amsterdam NL , (20130718), vol. 154, no. 2, doi:10.1016/j.cell.2013.06.044, ISSN 0092-8674, pages 442 - 451, XP055115843
OPPOSITION- Yamamoto A. et al, "Current prospects for mRNA gene delivery", European journal of pharmaceutics and biopharmaceutics, ELSEVIER SCIENCE PUBLISHERS B.V., AMSTERDAM., NL, NL , (20090301), vol. 71, no. 3, doi:10.1016/j.ejpb.2008.09.016, ISSN 0939-6411, pages 484 - 489, XP025992169
OPPOSITION- Karikó K, Buckstein M, Ni H, Weissman D, "Suppression of RNA recognition by Toll-like receptors: The impact of nucleoside modification and the evolutionary origin of RNA", Immunity, Cell Press, AMSTERDAM, NL, AMSTERDAM, NL , (20050801), vol. 23, no. 2, doi:10.1016/J.IMMUNI.2005.06.008, ISSN 1074-7613, pages 165 - 175, XP002634064
OPPOSITION- Heyes, J. Palmer, L. Bremner, K. MacLachlan, I., "Cationic lipid saturation influences intracellular delivery of encapsulated nucleic acids", Journal of Controlled Release, Elsevier, AMSTERDAM, NL, AMSTERDAM, NL , (20051003), vol. 107, no. 2, doi:10.1016/j.jconrel.2005.06.014, ISSN 0168-3659, pages 276 - 287, XP005076220
OPPOSITION- Geertrui Tavernier, Oliwia Andries, Jo Demeester, Niek N. Sanders, Stefaan C. De Smedt, Joanna Rejman, "mRNA as gene therapeutic: How to control protein expression", Journal of Controlled Release, Elsevier, (20110301), vol. 150, no. 3, doi:10.1016/j.jconrel.2010.10.020, ISSN 01683659, pages 238 - 247, XP055068617
OPPOSITION- Federico Perche; Thierry Benvegnu; Mathieu Berchel; Loic Lebegue; Chantal Pichon; Paul-Alain Jaffrà ̈s; Patrick Midoux;, "Enhancement of dendritic cells transfection in vivo and of vaccination against B16F10 melanoma with mannosylated histidylated lipopolyplexes loaded with tumor antigen messenger RNA", Nanomedicine: Nanotechnology, Biology, and Medicine, ELSEVIER, AMSTERDAM, NL, AMSTERDAM, NL, (20101229), vol. 7, no. 4, doi:10.1016/j.nano.2010.12.010, ISSN 1549-9634, pages 445 - 453, XP028248026
OPPOSITION- Luigi Warren, Philip D. Manos, Tim Ahfeldt, Yuin-Han Loh, Hu Li, Frank Lau, Wataru Ebina, Pankaj K. Mandal, Zachary D. Smith, Alexander Meissner, George Q. Daley, Andrew S. Brack, James J. Collins, Chad Cowan, Thorsten M. Schlaeger and Derrick J. Rossi, "Highly efficient reprogramming to pluripotency and directed differentiation of human cells with synthetic modified mRNA.", Cell Stem Cell, Elsevier, Cell Press, AMSTERDAM, NL, AMSTERDAM, NL , (20101105), vol. 7, no. 5, doi:10.1016/J.STEM.2010.08.012, ISSN 1934-5909, pages 618 - 630, XP002640639
OPPOSITION- Xingfang Su, Jennifer Fricke, Daniel G. Kavanagh, Darrell J. Irvine, "In Vitro and in Vivo mRNA Delivery Using Lipid-Enveloped pH-Responsive Polymer Nanoparticles", Molecular Pharmaceutics, American Chemical Society, (20110606), vol. 8, no. 3, doi:10.1021/mp100390w, ISSN 15438384, pages 774 - 787, XP055127583
OPPOSITION- Manuela Villion, Sylvain Moineau, "The double-edged sword of CRISPR-Cas systems", Cell Research, (20130101), vol. 23, no. 1, doi:10.1038/cr.2012.124, ISSN 10010602, pages 15 - 17, XP055086684
OPPOSITION- Nannan Chang, Changhong Sun, Lu Gao, Dan Zhu, Xiufei Xu, Xiaojun Zhu, Jig-Wei Xiong, Jianzhong Jeff Xi, "Genome editing with RNA-guided Cas9 nuclease in Zebrafish embryos", Cell Research, Springer Singapore, Singapore, Singapore , (20130401), vol. 23, no. 4, doi:10.1038/cr.2013.45, ISSN 1001-0602, pages 465 - 472, XP055251146
OPPOSITION- Bin Shen, Jun Zhang, Hongya Wu, Jianying Wang, Ke Ma, Zheng Li, Xueguang Zhang, Pumin Zhang, Xingxu Huang, "Generation of gene-modified mice via Cas9/RNA-mediated gene targeting", Cell Research, Springer Singapore, Singapore, Singapore , (20130501), vol. 23, no. 5, doi:10.1038/cr.2013.46, ISSN 1001-0602, pages 720 - 723, XP055141533
OPPOSITION- Carroll D, "Progress and prospects: Zinc-finger nucleases as gene therapy agents", Gene Therapy, Nature Publishing Group, London, GB, GB , (20080911), vol. 15, no. 22, doi:10.1038/gt.2008.145, ISSN 0969-7128, pages 1463 - 1468, XP037774186
OPPOSITION- KARIKÓ KATALIN ET AL, "Incorporation of pseudouridine into mRNA yields superior nonimmunogenic vector with increased translational capacity and biological stability.", Molecular Therapy, Nature Publishing Group, GB, GB , (20081101), vol. 16, no. 11, doi:10.1038/mt.2008.200, ISSN 1525-0024, pages 1833 - 1840, XP002598556
OPPOSITION- Akinc A., ET AL, "Development of Lipidoid�siRNA Formulations for Systemic Delivery to the Liver", Molecular Therapy, Elsevier Inc., US, US , (20090501), vol. 17, no. 5, doi:10.1038/MT.2009.36, ISSN 1525-0016, pages 872 - 879, XP008105983
OPPOSITION- LIU YANG, HUANG LEAF, "Designer Lipids Advance Systemic siRNA Delivery", Molecular Therapy, Elsevier Inc., US, US , (20100401), vol. 18, no. 4, doi:10.1038/MT.2010.39, ISSN 1525-0016, pages 669 - 670, XP002684383
OPPOSITION- Wang Yuhua; Su Hsing-Hao; Yang Yang; Hu Yunxia; Zhang Lu; Blancafort Pilar; Huang Leaf, "Systemic delivery of modified mRNA encoding herpes simplex virus 1 thymidine kinase for targeted cancer gene therapy.", Molecular Therapy, Nature Publishing Group, GB, GB , (20130201), vol. 21, no. 2, doi:10.1038/mt.2012.250, ISSN 1525-0024, pages 358 - 367, XP009170717
OPPOSITION- Karikó K, Muramatsu H, Keller J M, Weissman D., "Increased erythropoiesis in mice injected with submicrogram quantities of pseudouridine-containing mRNA encoding erythropoietin.", Molecular Therapy, Nature Publishing Group, GB, GB , (20120501), vol. 20, no. 5, doi:10.1038/mt.2012.7, ISSN 1525-0024, pages 948 - 953, XP002696191
OPPOSITION- URNOV F D ET AL, "Highly efficient endogenous human gene correction using designed zinc-finger nucleases.", Nature, Nature Publishing Group UK, London, London, (20050602), vol. 435, no. 7042, doi:10.1038/nature03556, ISSN 0028-0836, pages 646 - 651, XP002411069
OPPOSITION- Elitza Deltcheva, Krzysztof Chylinski, Cynthia M. Sharma, Karine Gonzales, Yanjie Chao, Zaid A. Pirzada, Maria R. Eckert, Jörg Vogel, Emmanuelle Charpentier, "CRISPR RNA maturation by trans-encoded small RNA and host factor RNase III", Nature, Nature Publishing Group UK, London, London, (20110331), vol. 471, no. 7340, doi:10.1038/nature09886, ISSN 0028-0836, pages 602 - 607,2pp, XP055068535
OPPOSITION- Michael S D Kormann, Günther Hasenpusch, Manish K Aneja, Gabriela Nica, Andreas W Flemmer, Susanne Herber-Jonat, Marceline Huppmann, Lauren E Mays, Marta Illenyi, Andrea Schams, Matthias Griese, Iris Bittmann, Rupert Handgretinger, Dominik Hartl, Joseph Rosenecker & Carsten Rudolph, "Expression of therapeutic proteins after delivery of chemically modified mRNA in mice.", Nature Biotechnology, (20110201), vol. 29, no. 2, doi:10.1038/nbt.1733, ISSN 1546-1696, pages 154 - 157, XP002696192
OPPOSITION- Jeffrey C Miller, Siyuan Tan, Guijuan Qiao, Kyle A Barlow, Jianbin Wang, Danny F Xia, Xiangdong Meng, David E Paschon, Elo Leung, Sarah J Hinkley, Gladys P Dulay, Kevin L Hua, Irina Ankoudinova, Gregory J Cost, Fyodor D Urnov, H Steve Zhang, Michael C Holmes, Lei Zhang, Philip D Gregory & Edward J Rebar, "A TALE nuclease architecture for efficient genome editing.(includes Online Methods)", Nature Biotechnology, (20110201), vol. 29, no. 2, doi:10.1038/nbt.1755, ISSN 1546-1696, pages 143 - 148+2pp, XP002685898
OPPOSITION- Feng Zhang, Le Cong, Simona Lodato, Sriram Kosuri, George M Church, Paola Arlotta, "Efficient construction of sequence-specific TAL effectors for modulating mammalian transcription", Nature Biotechnology, Gale Group Inc., (20110201), vol. 29, no. 2, doi:10.1038/nbt.1775, ISSN 10870156, pages 149 - 153, XP055005146
OPPOSITION- Rodolphe Barrangou, "RNA-mediated programmable DNA cleavage", Nature Biotechnology, Nature Publishing Group US, New York, New York, (20120910), vol. 30, no. 9, doi:10.1038/nbt.2357, ISSN 1087-0156, pages 836 - 838, XP055118675
OPPOSITION- Woong Y Hwang, Yanfang Fu, Deepak Reyon, Morgan L Maeder, Shengdar Q Tsai, Jeffry D Sander, Randall T Peterson, J-R Joanna Yeh, J Keith Joung, "Efficient genome editing in zebrafish using a CRISPR-Cas system", Nature Biotechnology, Nature Publishing Group US, New York, New York, (20130301), vol. 31, no. 3, doi:10.1038/nbt.2501, ISSN 1087-0156, pages 227 - 229, XP055540933
OPPOSITION- Woong Y Hwang, Yanfang Fu, Deepak Reyon, Morgan L Maeder, Shengdar Q Tsai, Jeffry D Sander, Randall T Peterson, J-R Joanna Yeh & J Keith Joung, "Supplementary Material to: Efficient genome editing in zebrafish using a CRISPR-Cas system", Nature Biotechnology, Nature Publishing Group US, New York, New York, (20130101), vol. 31, no. 3, doi:10.1038/nbt.2501, ISSN 1087-0156, pages 1 - 21, XP002718602
OPPOSITION- Seung Woo Cho, Sojung Kim, Jong Min Kim, Jin-Soo Kim, "Targeted genome engineering in human cells with the Cas9 RNA-guided endonuclease (includes Supplementary information)", Nature Biotechnology, Nature Publishing Group US, New York, New York, (20130301), vol. 31, no. 3, doi:10.1038/nbt.2507, ISSN 1087-0156, pages 230 - 232+1-11, XP002699850
OPPOSITION- Yanfang Fu, Jennifer A Foden, Cyd Khayter, Morgan L Maeder, Deepak Reyon, J Keith Joung, Jeffry D Sander, "High-frequency off-target mutagenesis induced by CRISPR-Cas nucleases in human cells", Nature Biotechnology, Gale Group Inc., (20130623), vol. 31, no. 9, doi:10.1038/nbt.2623, ISSN 10870156, pages 822 - 826, XP055133334
OPPOSITION- Jeffry D Sander, J Keith Joung, "CRISPR-Cas systems for editing, regulating and targeting genomes", Nature Biotechnology, Gale Group Inc., vol. 32, no. 4, doi:10.1038/nbt.2842, ISSN 10870156, pages 347 - 355, XP055172520
OPPOSITION- Maeder M L, Linder S J, Cascio V M, Fu Y, Ho Q H, Joung J K., "CRISPR RNA-guided activation of endogenous human genes", Nature Methods, Nature Publishing Group US, New York, New York, (20131001), vol. 10, no. 10, doi:10.1038/nmeth.2598, ISSN 1548-7091, pages 977 - 979 + 1 - 2, XP002736341
OPPOSITION- Perez-Pinera P, Kocak D D, Vockley C M, Adler A F, Kabadi A M, Polstein L R, Thakore P I, Glass K A, Ousterout D G, Leong K W, Guilak F, Crawford G E, Reddy T E, Gersbach C A., "RNA-guided gene activation by CRISPR-Cas9-based transcription factors.", NATURE METHODS, Nature Publishing Group, GB, GB , (20131001), vol. 10, no. 10, doi:10.1038/nmeth.2600, ISSN 1548-7105, pages 973 - 976, XP002738748
OPPOSITION- Prashant Mali, Kevin M Esvelt & George M Church, "Cas9 as a versatile tool for engineering biology.", NATURE METHODS, Nature Publishing Group, GB, GB , (20131001), vol. 10, no. 10, doi:10.1038/nmeth.2649 , ISSN 1548-7105, pages 957 - 963, XP002718606
OPPOSITION- Neville E Sanjana, Cong Le, Zhou Yang, Cunniff Margaret M, Feng Guoping, Zhang Feng, "A transcription activator-like effector toolbox for genome engineering", Nature Protocols, Nature Publishing Group, GB, GB , (20120105), vol. 7, no. 1, doi:10.1038/nprot.2011.431, ISSN 1754-2189, pages 171 - 192, XP055548736
OPPOSITION- Ugur Sahin, Katalin Karikó, Özlem Türeci, "mRNA-based therapeutics — developing a new class of drugs", Nature Reviews Drug Discovery, Nature Publishing Group, GB, GB , (20141001), vol. 13, no. 10, doi:10.1038/nrd4278, ISSN 1474-1776, pages 759 - 780, XP055544673
OPPOSITION- Fyodor D. Urnov, Edward J. Rebar, Michael C. Holmes, H. Steve Zhang & Philip D. Gregory, "Genome editing with engineered zinc finger nucleases", Nature Reviews: Genetics, Nature Publishing Group, United Kingdom, United Kingdom , (20100901), vol. 11, no. 9, doi:10.1038/nrg2842, ISSN 1471-0064, pages 636 - 646, XP008150557
OPPOSITION- J. Keith Joung, Sander Jeffry D., "TALENs: a widely applicable technology for targeted genome editing", Nature Reviews Molecular Cell Biology, Nature Publishing Group UK, London, London, (20121121), vol. 14, no. 1, doi:10.1038/nrm3486, ISSN 1471-0072, pages 49 - 55, XP055282847
OPPOSITION- Makarova Kira S; Haft Daniel H; Barrangou Rodolphe; Brouns Stan J J; Charpentier Emmanuelle; Horvath Philippe; Moineau Sylvain; Mojica Francisco J M; Wolf Yuri I; Yakunin Alexander F; van der Oost John; Koonin Eugene V, "Evolution and classification of the CRISPR-Cas systems", Nature Reviews Microbiology, NATURE PUBLISHING GROUP, GB, GB , (20110509), vol. 9, no. 6, doi:10.1038/nrmicro2577, ISSN 1740-1526, pages 467 - 477, XP009155547
OPPOSITION- Khorsandi S E; Bachellier P; Weber J C; Greget M; Jaeck D; Zacharoulis D; Rountas C; Helmy S; Helmy A; Al-Waracky M; Salama H; Jiao L; Nicholls J; Davies A J; Levicar N; Jensen S; Habib N, "Minimally invasive and selective hydrodynamic gene therapy of liver segments in the pig and human", Cancer Gene Therapy, Nature Publishing Group US, New York, New York, (20080208), vol. 15, no. 4, doi:10.1038/sj.cgt.7701119, ISSN 0929-1903, pages 225 - 230, XP037762097
OPPOSITION- Harper S E, Qiu Y, Sharp P A, "Sin3 corepressor function in Myc-induced transcription and transformation.", Proceedings of the National Academy of Sciences, National Academy of Sciences, (19960806), vol. 93, no. 16, doi:10.1073/pnas.93.16.8536, ISSN 0027-8424, pages 8536 - 8540, XP055932453
OPPOSITION- YAGI MAYUMI ET AL, "Sustained ex vivo expansion of hematopoietic stem cells mediated by thrombopoietin.", Proceedings of the National Academy of Sciences, National Academy of Sciences, (19990706), vol. 96, no. 14, doi:10.1073/pnas.96.14.8126, ISSN 0027-8424, pages 8126 - 8131, XP002138207
OPPOSITION- Y.-S. Dai, Et Al, "The Transcription Factors GATA4 and dHAND Physically Interact to Synergistically Activate Cardiac Gene Expression through a p300-dependent Mechanism", Journal of Biological Chemistry, American Society for Biochemistry and Molecular Biology, US, US , (20020705), vol. 277, no. 27, doi:10.1074/jbc.M202490200, ISSN 0021-9258, pages 24390 - 24398, XP055251716
OPPOSITION- S. L. Planey, Et Al, "Inhibition of Glucocorticoid-induced Apoptosis in 697 Pre-B Lymphocytes by the Mineralocorticoid Receptor N-terminal Domain", Journal of Biological Chemistry, American Society for Biochemistry and Molecular Biology, US, US , (20021101), vol. 277, no. 44, doi:10.1074/jbc.M205085200, ISSN 0021-9258, pages 42188 - 42196, XP055251719
OPPOSITION- J. E. Dicarlo, J. E. Norville, P. Mali, X. Rios, J. Aach, G. M. Church, "Genome engineering in Saccharomyces cerevisiae using CRISPR-Cas systems", Nucleic Acids Research, Information Retrieval Ltd., (20130401), vol. 41, no. 7, doi:10.1093/nar/gkt135, ISSN 03051048, pages 4336 - 4343, XP055086617
OPPOSITION- P. Blancafort, "Designing Transcription Factor Architectures for Drug Discovery", Molecular Pharmacology, American Society for Pharmacology and Experimental Therapeutics, (20040101), vol. 66, no. 6, doi:10.1124/mol.104.002758, ISSN 0026895X, pages 1361 - 1371, XP055015595
OPPOSITION- M. Jinek, K. Chylinski, I. Fonfara, M. Hauer, J. A. Doudna, E. Charpentier, "A Programmable Dual-RNA-Guided DNA Endonuclease in Adaptive Bacterial Immunity", Science, American Association for the Advancement of Science, US, US , (20120817), vol. 337, no. 6096, doi:10.1126/science.1225829, ISSN 0036-8075, pages 816 - 821, XP055299674
OPPOSITION- S. J. J. Brouns, "A Swiss Army Knife of Immunity", Science, American Association for the Advancement of Science, (20120817), vol. 337, no. 6096, doi:10.1126/science.1227253, ISSN 00368075, pages 808 - 809, XP055113718
OPPOSITION- Mali Et Al., "RNA-guided human genome engineering via Cas9", Science, American Association for the Advancement of Science, US, US , (20130101), vol. 339, doi:10.1126/science.1232033, ISSN 0036-8075, pages 823 - 826, XP055362871
OPPOSITION- PRASHANT MALI, LUHAN YANG, KEVIN M. ESVELT, JOHN AACH, MARC GUELL, JAMES E. DICARLO, JULIE E. NORVILLE, GEORGE M. CHURCH, "Supplementary Materials for RNA-Guided Human Genome Engineering via Cas9", Science, American Association for the Advancement of Science, US, US , vol. 339, no. 6121, doi:10.1126/science.1232033, ISSN 0036-8075, (20130215), pages 1 - 36, Science, URL: http://www.sciencemag.org/content/suppl/2013/01/03/science.1232033.DC1, XP002723674
OPPOSITION- Lauren E. Mays, Susanne Ammon-Treiber, Benedikt Mothes, Mohammed Alkhaled, Jennifer Rottenberger, Eva Sophie Müller-Hermelink, Melanie Grimm, Markus Mezger, Sandra Beer-Hammer, Esther Von Stebut, Nikolaus Rieber, Bernd Nürnberg, Matthias Schwab, Rupert Handgretinger, Marco Idzko, Dominik Hartl, Michael S.D. Kormann, "Modified Foxp3 mRNA protects against asthma through an IL-10–dependent mechanism", Journal of Clinical Investigation, (20130301), vol. 123, no. 3, doi:10.1172/JCI65351, ISSN 00219738, pages 1216 - 1228, XP055159538
OPPOSITION- Kalejs Martins; Erenpreisa Jekaterina, "Cancer/testis antigens and gametogenesis: a review and "brain-storming" session", CANCER CELL INTERNATIONAL, BIOMED CENTRAL, LONDON, GB, GB , (20050216), vol. 5, no. 1, doi:10.1186/1475-2867-5-4, ISSN 1475-2867, page 4, XP021007366
OPPOSITION- Kira S Makarova;L Aravind;Yuri I Wolf;Eugene V Koonin, "Unification of Cas protein families and a simple scenario for the origin and evolution of CRISPR-Cas systems", Biology Direct, BioMed Central, (20110714), vol. 6, no. 1, doi:10.1186/1745-6150-6-38, ISSN 1745-6150, pages 1 - 27, XP021105829
OPPOSITION- S.-T. Chou, Q. Leng, J. Mixson, "Zinc finger nucleases: Tailor-made for gene therapy", Drugs of the Future, Prous Science, ES, ES , (20120101), vol. 37, no. 3, doi:10.1358/dof.2012.037.03.1779022, ISSN 0377-8282, page 183, XP055512500
OPPOSITION- Christopher S. Raymond, Philippe Soriano, "High-Efficiency FLP and ΦC31 Site-Specific Recombination in Mammalian Cells", PLoS ONE, Public Library of Science, US, US , (20070101), vol. 2, no. 1, doi:10.1371/journal.pone.0000162, ISSN 1932-6203, pages 1 - 4, XP055069825
OPPOSITION- Michelle Christian et al, "Targeting DNA Double-Strand Breaks with TAL Effector Nucleases (plus supporting information)", GENETICS, GENETICS SOCIETY OF AMERICA, AUSTIN, TX, US, US , (20101001), vol. 186, no. 2, doi:10.1534/GENETICS.110.120717, ISSN 0016-6731, pages 757 - 761, 1SI-8SI, XP002632806
OPPOSITION- D. Carroll, "Genome Engineering With Zinc-Finger Nucleases", Genetics, Genetics Society of America [etc.], (20110801), vol. 188, no. 4, doi:10.1534/genetics.111.131433, ISSN 00166731, pages 773 - 782, XP055036700
OPPOSITION- S. J. Gratz, A. M. Cummings, J. N. Nguyen, D. C. Hamm, L. K. Donohue, M. M. Harrison, J. Wildonger, K. M. O'connor-Giles, "Genome Engineering of Drosophila with the CRISPR RNA-Guided Cas9 Nuclease", Genetics, Genetics Society of America [etc.], (20130801), vol. 194, no. 4, doi:10.1534/genetics.113.152710, ISSN 00166731, pages 1029 - 1035, XP055102690
OPPOSITION- Z. Yu, M. Ren, Z. Wang, B. Zhang, Y. S. Rong, R. Jiao, G. Gao, "Highly Efficient Genome Modifications Mediated by CRISPR/Cas9 in Drosophila (includes Supporting Information)", GENETICS, GENETICS SOCIETY OF AMERICA, AUSTIN, TX, US, US , (20130901), vol. 195, no. 1, doi:10.1534/genetics.113.153825, ISSN 0016-6731, pages 289 - 291,1-14, XP055242275
OPPOSITION- Thomas Schlake, Andreas Thess, Mariola Fotin-Mleczek, Karl-Josef Kallen, "Developing mRNA-vaccine technologies", RNA BIOLOGY, (20121101), vol. 9, no. 11, doi:10.4161/rna.22269, ISSN 1547-6286, pages 1319 - 1330, XP055561756
OPPOSITION- Krzysztof Chylinski, Anaïs Le Rhun, Emmanuelle Charpentier, "The tracrRNA and Cas9 families of type II CRISPR-Cas immunity systems", RNA Biology, Landes Bioscience, (20130501), vol. 10, no. 5, doi:10.4161/rna.24321, ISSN 15476286, pages 726 - 737, XP055116068
OPPOSITION- Martin Jinek, Alexandra East, Aaron Cheng, Steven Lin, Enbo Ma, Jennifer Doudna, "RNA-programmed genome editing in human cells.", eLife, eLife Sciences Publications Ltd., GB, GB , (20130129), vol. 2, doi:10.7554/eLife.00471, ISSN 2050-084X, pages e00471 - e00471-9, XP002699851
SEARCH- DERRIGO M ET AL, "RNA-PROTEIN INTERACTIONS IN THE CONTROL OF STABILITY AND LOCALIZATION OF MESSENGER RNA (REVIEW)", INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, SPANDIDOS PUBLICATIONS, GR, (20000201), vol. 5, no. 2, ISSN 1107-3756, pages 111 - 123, XP008034329 [Y] 3-6,9-15 * the whole document *-
SEARCH- LEI S. QI ET AL, "Repurposing CRISPR as an RNA-Guided Platform for Sequence-Specific Control of Gene Expression", CELL, US, (20130201), vol. 152, no. 5, doi:10.1016/j.cell.2013.02.022, ISSN 0092-8674, pages 1173 - 1183, XP055299671 [A] 1-15 * the whole document *
SEARCH- WANG HAOYI ET AL, "One-Step Generation of Mice Carrying Mutations in Multiple Genes by CRISPR/Cas-Mediated Genome Engineering", CELL, CELL PRESS, US, (20130502), vol. 153, no. 4, doi:10.1016/J.CELL.2013.04.025, ISSN 0092-8674, pages 910 - 918, XP028538358 [I] 1,2,7,8 * the whole document * [Y] 3-6,9-15
SEARCH- LUKE A. GILBERT ET AL, "CRISPR-Mediated Modular RNA-Guided Regulation of Transcription in Eukaryotes", CELL, US, (20130711), vol. 154, no. 2, doi:10.1016/j.cell.2013.06.044, ISSN 0092-8674, pages 442 - 451, XP055321615 [AP] 1-15 * the whole document *
SEARCH- MICHAEL S D KORMANN ET AL, "Expression of therapeutic proteins after delivery of chemically modified mRNA in mice", NATURE BIOTECHNOLOGY, (20110201), vol. 29, no. 2, doi:10.1038/nbt.1733, ISSN 1087-0156, pages 154 - 157, XP055040839 [Y] 3-6,9-15 * the whole document *
SEARCH- MORGAN L MAEDER ET AL, "CRISPR RNA-guided activation of endogenous human genes", HHS PUBLIC ACCESS AUTHOR MANUSCRIPT, GB, (20130725), vol. 10, no. 10, doi:10.1038/nmeth.2598, ISSN 1548-7091, pages 977 - 979, XP055291599 [AP] 1-15 * the whole document *
SEARCH- PABLO PEREZ-PINERA ET AL, "RNA-guided gene activation by CRISPR-Cas9-based transcription factors", NATURE METHODS, (20130725), vol. 10, no. 10, doi:10.1038/nmeth.2600, ISSN 1548-7091, pages 973 - 976, XP055181249 [AP] 1-15 * the whole document *

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents